Antigenic and phenotypic modifications of Yersinia pestis under calcium and glucose concentrations simulating the mammalian bloodstream environment.
To study the possible mechanism of extracellular resistance to phagocytes developed by Yersinia pestis in the early stage of plague infection, the behaviour of two Y. pestis strains, the vaccine EV-76 and fully virulent 231 (LD(50), 10 c.f.u.), was studied in-depth after cultivation in vitro at the host temperature in conditions simulating the bloodstream environment of mammals. For this, two standard basal media supplemented with calcium and glucose in appropriate concentrations were employed: Hottinger broth, routinely used for growth of Y. pestis in vitro, and RPMI 1640, simulating human extracellular fluid. Although both media permitted Y. pestis to achieve the resistant state, RPMI enabled significantly higher bacterial proliferation and increased modifications in the production of the principal surface antigens that affect the relevant phenotype characteristics. In general, our results indicate that the Y. pestis bacteria in the resistant state do not produce species-specific antigens, i.e. fraction 1 or F1, 'murine' toxin or Ymt, plasminogen activator (Pla) and any surface-specific polysaccharides, resulting in unmasking of the cross-reactive epitopes of lipid A in reduced Y. pestis lipopolysaccharide. This may produce mimicry by Y. pestis of some human tissue and blood cell components, with no immune response and inflammation at the site of infection at the early stage, which enables Y. pestis to survive, extensively multiply and spread into the circulation.
Feodorova
Valentina A
VA
Laboratory of Hybridomas, Russia State Antiplague Research Institute 'Microbe', Saratov, Universitetskaya, 46, Saratov, 410005, Russia.
Golova
Alina B
AB
Laboratory of Hybridomas, Russia State Antiplague Research Institute 'Microbe', Saratov, Universitetskaya, 46, Saratov, 410005, Russia.
D000222:Adaptation, Physiological; D000942:Antigens, Bacterial / Q000032:analysis / Q000096:biosynthesis; D001426:Bacterial Proteins / Q000032:analysis / Q000096:biosynthesis; D002118:Calcium; D003470:Culture Media; D005947:Glucose; D008050:Lipid A / Q000032:analysis / Q000096:biosynthesis; D010587:Phagocytosis; D010641:Phenotype; D010960:Plasminogen Activators / Q000032:analysis / Q000096:biosynthesis; D015010:Yersinia pestis / Q000254:growth & development / Q000472:pathogenicity / Q000502:physiology*
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D003470:Culture Media; D008050:Lipid A; C086725:caf1 protein, Yersinia pestis; D010960:Plasminogen Activators; D005947:Glucose; D002118:Calcium